COMPARING THE EFFICACY OF  4 MG VS 2 MG INTRAVITREAL TRIAMCINOLONE ACETONIDE IN THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA

N AADIL; HM WAQAS; M FATIMA; SS KHAN

doi:10.54112/bcsrj.v2023i1.223

Authors

N AADIL Department of Ophthalmology, Nishtar Medical University, and Hospital (NMU&H), Multan, Pakistan
HM WAQAS Department of Ophthalmology (Vitreo-Retina), Nishtar Medical University and Hospital (NMU&H), Multan, Pakistan
M FATIMA Department of Ophthalmology, Nishtar Medical University, and Hospital (NMU&H), Multan, Pakistan
SS KHAN Department of Ophthalmology, Bakhtawar Amin Hospital Multan, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.223

Keywords:

Triamcinolone acetonide, Intravitreal injections, Diabetic macular edema, Macular thickening, Visual acuity

Abstract

The prospective study was conducted in the Department of Ophthalmology from January 2022 to January 2023 to compare the effectiveness of two doses of TA on DME using central macular thickness (CMT) as the primary criterion. A total of 30 patients were included in the study. Participants were randomly divided into a 4mg TA group (n=16) and a 2 mg TA group(n=16). The injection was given in the eye with higher CMT. Patients were followed up until 6 months after injection. Results showed that regarding mean CMT and change in macular thickness, there was no statistically significant difference between both groups during the whole study period. After 1 month of injection, the ETDRS score in the 4 mg group increased significantly from 37.7±14.1 to 51.3±14.3 (P=0.0012) and from 41.9± 13.3 to 49.4± 13.7 in the 2mg group (P=0.002). Based on the results it can be concluded that the intravitreal 2 mg or 4 mg TA injection had a similar effect on both VA and CMT in patients with DME.

Downloads

Download data is not yet available.

References

Abdel-Maboud, M., Menshawy, E., Bahbah, E. I., Outani, O., and Menshawy, A. (2021). Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema–Systematic review, meta-analysis and meta-regression. Plos one 16, e0245010.

Allmendinger, A., Butt, Y. L., and Mueller, C. (2021). Intraocular pressure and injection forces during intravitreal injection into enucleated porcine eyes. European Journal of Pharmaceutics and Biopharmaceutics 166, 87-93.

Anwar, F., Khan, A. A., Majhu, T. M., Javaid, R. M. M., Ghaffar, M. T., and Bokhari, M. H. (2022). Comparison of Suprachoroidal Injection of Triamcinolone Acetonide Versus Intravitreal Bevacizumab in Primary Diabetic Macular Odema. Pakistan Journal of Medical & Health Sciences 16, 304-304.

Carreira, A. R., Marques, N., Carreira, P., Moraes, F., Loureiro, T., Telles Freitas, P., Cardoso, J., and Campos, N. (2022). Safety of intravitreal triamcinolone and its impact on optic nerve morphology in patients treated for diabetic macular edema. European Journal of Ophthalmology 32, 1596-1601.

Chauhan, M. Z., Rather, P. A., Samarah, S. M., Elhusseiny, A. M., and Sallam, A. B. (2022). Current and novel therapeutic approaches for treatment of diabetic macular edema. Cells 11, 1950.

Cheng, T., Li, J., Cheng, Y., Zhang, X., and Qu, Y. (2019). Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops. Experimental Eye Research 188, 107805.

Everett, L. A., and Paulus, Y. M. (2021). Laser therapy in the treatment of diabetic retinopathy and diabetic macular edema. Current Diabetes Reports 21, 1-12.

Jayadev, C., Gadde, S. G., and Kumar, A. A. (2023). Laser Photocoagulation for Diabetic Macular Edema. In "Diabetic Macular Edema", pp. 107-118. Springer.

Kusumowidagdo, G., Sarayar, R., Rahayu, K., and Andayani, G. (2019). Current Therapy of Diabetic Macular Edema Bevacizumab, Triamcinolone Acetonide, and Laser Photocoagulation. Ophthalmologica Indonesiana 45, 13-13.

Li, X., Hu, X., Yu, L., Zhu, L., Fu, C.-W., and Heng, P.-A. (2019). CANet: cross-disease attention network for joint diabetic retinopathy and diabetic macular edema grading. IEEE transactions on medical imaging 39, 1483-1493.

Maeda, Y., Ishikawa, H., Nishikawa, H., Shimizu, M., Kinoshita, T., Ogihara, R., Kitano, S., Yamanaka, C., Mitamura, Y., and Sugimoto, M. (2019). Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan. PLoS One 14, e0226118.

Markan, A., Agarwal, A., Arora, A., Bazgain, K., Rana, V., and Gupta, V. (2020). Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema. Therapeutic Advances in Ophthalmology 12, 2515841420950513.

Rodríguez, M. L., Pérez, S., Mena-Mollá, S., Desco, M. C., and Ortega, Á. L. (2019). Oxidative stress and microvascular alterations in diabetic retinopathy: Future Therapies. Oxidative Medicine and Cellular Longevity 2019.

Tariq, F., Wang, Y., Ma, B., He, Y., Zhang, S., and Bai, L. (2022). Efficacy of intravitreal injection of filtered modified low-dose triamcinolone acetonide and ranibizumab on pseudophakic cystoid macular edema. Frontiers in Medicine 9.

Zur, D., Iglicki, M., and Loewenstein, A. (2019). The role of steroids in the management of diabetic macular edema. Ophthalmic Research 62, 231-236.